IPO Announced

Hemab Therapeutics Holdings IPO

US$302m raised

Lodged 30 Apr 2026 · NASDAQ: COAG

Advisers

Hemab Therapeutics Holdings

Issuer

Legal adviser

Lead managers

Lead manager
Legal adviser
Issuer
Hemab Therapeutics Holdings
Issuer based in
United States
Sector
Biotech
Tags
Biotech, Pharma

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.